D
David M. Hwang
Researcher at Sunnybrook Health Sciences Centre
Publications - 184
Citations - 9146
David M. Hwang is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Lung transplantation & Lung. The author has an hindex of 48, co-authored 179 publications receiving 7241 citations. Previous affiliations of David M. Hwang include Toronto General Hospital & University Health Network.
Papers
More filters
Journal ArticleDOI
Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Tereza Martinu,H. Oishi,Stephen C. Juvet,Marcelo Cypel,Mingyao Liu,Gerald J. Berry,David M. Hwang,Shaf Keshavjee +7 more
TL;DR: Assessments can make the murine LTx model a more useful tool for further mechanistic studies of CLAD pathogenesis, and grading of pathologic changes demonstrated variable severity of airway fibrosis, PF, acute rejection, vascular fibrosis and epithelial changes, similar to those seen in human CLAD.
Journal ArticleDOI
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC.
Mari Mino-Kenudson,Nolwenn Le Stang,Jillian B. Daigneault,Andrew G. Nicholson,Andrew G. Nicholson,Wendy A Cooper,Anja C. Roden,Andre L. Moreira,Erik Thunnissen,Mauro Papotti,Giuseppe Pelosi,Noriko Motoi,Claudia Poleri,Elisabeth Brambilla,Mary W. Redman,Deepali Jain,Sanja Dacic,Yasushi Yatabe,Ming-Sound Tsao,Fernando Lopez-Rios,Johan Botling,Gang Chen,Teh Ying Chou,Fred R. Hirsch,Mary Beth Beasley,Alain C. Borczuk,Lukas Bubendorf,Jin Haeng Chung,David M. Hwang,Dongmei Lin,John W. Longshore,Masayuki Noguchi,Natasha Rekhtman,Lynette M. Sholl,William D. Travis,Akihiko Yoshida,Murry W. Wynes,Ignacio I. Wistuba,Keith M. Kerr,Sylvie Lantuejoul +39 more
TL;DR: The International Association for the Study of Lung Cancer Pathology Committee conducted a global survey for pathologists from January to May 2019, comprising multiple questions on preanalytical, analytical, and postanalytical conditions.
Journal ArticleDOI
Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non–small-cell Lung Cancer
Pascale Tomasini,Pascale Tomasini,Céline Mascaux,Kevin Jao,Catherine Labbé,Suzanne Kamel-Reid,Tracy Stockley,David M. Hwang,Natasha B. Leighl,Geoffrey Liu,Penelope A. Bradbury,Melania Pintilie,Ming-Sound Tsao,Frances A. Shepherd +13 more
TL;DR: OS was longer for patients with TP53 and KRAS wild-type NSCLC who received chemotherapy for any stage compared with patients with KRAS, TP53 mutation, or double mutant tumors, but there was no significant difference in DFS/PFS.
Journal ArticleDOI
Nonspecific interstitial pneumonia: a study of 6 patients with progressive disease.
TL;DR: Clinical presentations and histology of surgical biopsy-proven nonspecific interstitial pneumonia in 6 patients with clinical and radiologic progression, resulting in the need for rebiopsy or lung transplantation are described.
Journal ArticleDOI
A Practical Approach to Investigating Cross-Contaminants in the Anatomical Pathology Laboratory.
Anjelica Hodgson,Anjelica Hodgson,Yan Ming Shang,Patrice Boulianne,Michelle R. Downes,Michelle R. Downes,David M. Hwang,David M. Hwang,Elzbieta Slodkowska,Elzbieta Slodkowska +9 more
TL;DR: The steps involved in processing pathology specimens as they pertain to cross-contamination are reviewed; an approach covering how to troubleshoot and prevent tissue contaminants in a systematic and practical manner is shared; some examples from the authors' own experiences are presented; and their experience is compared to what is reported in the literature.